Literature DB >> 32558473

Reconsidering the Trade-offs of Prostate Cancer Screening.

Jonathan E Shoag1, Yaw A Nyame1, Roman Gulati1, Ruth Etzioni1, Jim C Hu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32558473      PMCID： PMC7491201          DOI： 10.1056/NEJMsb2000250

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  32 in total

1.  Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.

Authors:  Paul R Womble; James E Montie; Zaojun Ye; Susan M Linsell; Brian R Lane; David C Miller
Journal:  Eur Urol       Date:  2014-08-24       Impact factor: 20.096

2.  Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.

Authors:  Stacy Loeb; Nataliya Byrne; Danil V Makarov; Herbert Lepor; Dawn Walter
Journal:  JAMA       Date:  2018-06-05       Impact factor: 56.272

3.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

4.  Contingent Knowledge and Looping Effects - A 66-Year-Old Man with PSA-Detected Prostate Cancer and Regrets.

Authors:  Robert Aronowitz; Jeremy A Greene
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 91.245

5.  Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.

Authors:  Jun Li; David A Siegel; Jessica B King
Journal:  Ann Epidemiol       Date:  2018-03-06       Impact factor: 3.797

Review 6.  Recent Changes in Prostate Cancer Screening Practices and Epidemiology.

Authors:  Daniel J Lee; Katherine Mallin; Amy J Graves; Sam S Chang; David F Penson; Matthew J Resnick; Daniel A Barocas
Journal:  J Urol       Date:  2017-05-25       Impact factor: 7.450

7.  Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Authors:  Roman Gulati; John L Gore; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

8.  A study of sexuality and health among older adults in the United States.

Authors:  Stacy Tessler Lindau; L Philip Schumm; Edward O Laumann; Wendy Levinson; Colm A O'Muircheartaigh; Linda J Waite
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

9.  Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.

Authors:  Tyler M Seibert; Chun Chieh Fan; Yunpeng Wang; Verena Zuber; Roshan Karunamuni; J Kellogg Parsons; Rosalind A Eeles; Douglas F Easton; ZSofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch Garcia; Kenneth Muir; Henrik Grönberg; Fredrik Wiklund; Markus Aly; Johanna Schleutker; Csilla Sipeky; Teuvo Lj Tammela; Børge G Nordestgaard; Sune F Nielsen; Maren Weischer; Rasmus Bisbjerg; M Andreas Røder; Peter Iversen; Tim J Key; Ruth C Travis; David E Neal; Jenny L Donovan; Freddie C Hamdy; Paul Pharoah; Nora Pashayan; Kay-Tee Khaw; Christiane Maier; Walther Vogel; Manuel Luedeke; Kathleen Herkommer; Adam S Kibel; Cezary Cybulski; Dominika Wokolorczyk; Wojciech Kluzniak; Lisa Cannon-Albright; Hermann Brenner; Katarina Cuk; Kai-Uwe Saum; Jong Y Park; Thomas A Sellers; Chavdar Slavov; Radka Kaneva; Vanio Mitev; Jyotsna Batra; Judith A Clements; Amanda Spurdle; Manuel R Teixeira; Paula Paulo; Sofia Maia; Hardev Pandha; Agnieszka Michael; Andrzej Kierzek; David S Karow; Ian G Mills; Ole A Andreassen; Anders M Dale
Journal:  BMJ       Date:  2018-01-10

10.  Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Authors:  Alex Tsodikov; Roman Gulati; Eveline A M Heijnsdijk; Paul F Pinsky; Sue M Moss; Sheng Qiu; Tiago M de Carvalho; Jonas Hugosson; Christine D Berg; Anssi Auvinen; Gerald L Andriole; Monique J Roobol; E David Crawford; Vera Nelen; Maciej Kwiatkowski; Marco Zappa; Marcos Luján; Arnauld Villers; Eric J Feuer; Harry J de Koning; Angela B Mariotto; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2017-09-05       Impact factor: 25.391
View more
  17 in total

1.  An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer.

Authors:  Guian Zhang; Yong Luo
Journal:  Int J Gen Med       Date:  2021-11-30

Review 2.  Race and prostate cancer: genomic landscape.

Authors:  Camilo Arenas-Gallo; Jude Owiredu; Ilon Weinstein; Patrick Lewicki; Spyridon P Basourakos; Randy Vince; Bashir Al Hussein Al Awamlh; Fredrick R Schumacher; Daniel E Spratt; Christopher E Barbieri; Jonathan E Shoag
Journal:  Nat Rev Urol       Date:  2022-08-09       Impact factor: 16.430

3.  Long non-coding RNA SNHG3 promotes prostate cancer progression by sponging microRNA-1827.

Authors:  Ming Hu; Mingliang Ren; Zhenhua Zhao; Xuejiang Cui; Ming Shi; Yunjie Yang; Haiyan Guo
Journal:  Oncol Lett       Date:  2022-06-27       Impact factor: 3.111

Review 4.  Grade Migration of Prostate Cancer in the United States During the Last Decade.

Authors:  Leonardo D Borregales; Gina DeMeo; Xiangmei Gu; Emily Cheng; Vanessa Dudley; Edward M Schaeffer; Himanshu Nagar; Sigrid Carlsson; Andrew Vickers; Jim C Hu
Journal:  J Natl Cancer Inst       Date:  2022-07-11       Impact factor: 11.816

5.  The Modest Effects of Fact Boxes on Cancer Screening.

Authors:  Michael R Eber; Cass R Sunstein; James K Hammitt; Jennifer M Yeh
Journal:  J Risk Uncertain       Date:  2021-02-17

6.  Usability and diagnostic accuracy of different MRI/ultrasound-guided fusion biopsy systems for the detection of clinically significant and insignificant prostate cancer: a prospective cohort study.

Authors:  Ioannis Sokolakis; Nikolaos Pyrgidis; Lukas Koneval; Markus Krebs; Annette Thurner; Hubert Kübler; Georgios Hatzichristodoulou
Journal:  World J Urol       Date:  2021-06-17       Impact factor: 4.226

Review 7.  Problems with Numbers in Decision Aids for Prostate-specific Antigen Screening: A Critical Review.

Authors:  Sigrid V Carlsson; Andrew J Vickers; Jason P Gonsky; Jennifer L Hay; Jim C Hu
Journal:  Eur Urol       Date:  2020-12-09       Impact factor: 20.096

8.  When to Discuss Prostate Cancer Screening With Average-Risk Men.

Authors:  Roman Gulati; Sigrid V Carlsson; Ruth Etzioni
Journal:  Am J Prev Med       Date:  2021-05-06       Impact factor: 6.604

9.  Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer.

Authors:  Yaw A Nyame; Roman Gulati; Alex Tsodikov; John L Gore; Ruth Etzioni
Journal:  JNCI Cancer Spectr       Date:  2020-10-26

Review 10.  Active surveillance for prostate cancer.

Authors:  Daniela K Shill; Monique J Roobol; Behfar Ehdaie; Andrew J Vickers; Sigrid V Carlsson
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.